Your session is about to expire
← Back to Search
Exoskeleton Users for Paraplegia
N/A
Recruiting
Led By Sue Dahl-Popolizio, DBH
Research Sponsored by A.T. Still University of Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up check journal monthly up to 12 months
Awards & highlights
Study Summary
The purpose of this study is to observe current exoskeleton users in their home environment to determine the activities of daily living (ADLs) they are able to complete, and to identify the minor adaptations to the home environment that will improve the exoskeleton user's potential for increased independence. This is a pilot study to fine-tune the methods and to determine the feasibility of doing this study on a larger scale.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ check journal monthly up to 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~check journal monthly up to 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Brief Pain Inventory (BPI)
Canadian Occupational Performance Measure (COPM)
Reintegration to Normal Living Index - Modified for Exoskeleton
Secondary outcome measures
Journal Entries
Trial Design
1Treatment groups
Experimental Treatment
Group I: Exoskeleton UsersExperimental Treatment1 Intervention
This study includes patients who are current exoskeleton users. Exoskeleton users will engage in normal activities of daily living (ADLs) that they currently perform at wheelchair level while using the exoskeleton. Researchers will observe the ADLs the exoskeleton users are and are not able to complete while using their exoskeleton.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exoskeleton
2018
N/A
~70
Find a Location
Who is running the clinical trial?
A.T. Still University of Health SciencesLead Sponsor
20 Previous Clinical Trials
5,540 Total Patients Enrolled
Sue Dahl-Popolizio, DBHPrincipal InvestigatorA. T. Still University
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger